MiNDERA Corporation Company

MiNDERA Dx conducts research and development on non-invasive molecular testing for skin cancer and other skin diseases. The company is currently focused on a technology solution to extract skin biomarkers in a non-invasive manner.
MiNDERA Dx was founded in 2013 and is based in San Francisco, United States.
Technology: Personalized Diagnostics
Industry: Precision Medicine
Headquarters: South San Francisco
Founded Date: 2013
Employees Number: 11-50
Funding Status: undisclosed

Visit Website
Register and Claim Ownership